Tariq Musa sold $18K of GH
Tariq Musa sold 116 shares of Guardant Health, Inc. (GH) at $156.45 on 2026-08-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider trading activity but does not provide new company performance, guidance, or regulatory/product developments.
Market read
Traders may note the insider sale, but the 10b5-1 structure and small size suggest limited incremental information.
What to watch
The article does not disclose any buy/sell by other insiders, changes in guidance, or operational developments, limiting the ability to connect the sale to new fundamentals.
Background
The article is a SEC Form 4 insider transaction disclosure for Guardant Health, Inc.
Ticker impact
Guardant Health director Tariq Musa filed a Form 4 showing an open-market sale of 116 shares at $156.45 on 2026-08-17.
Low likelihood of a sustained price move based solely on this Form 4 sale.
The filing specifies a pre-arranged Rule 10b5-1 plan and a relatively small transaction size, which typically reduces interpretive weight versus unscheduled sales.
Market effects
No clear sector read-through from a single, small 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Even 10b5-1 sales can coincide with internal expectations, so some traders may still watch for follow-on insider activity or changes in trading patterns.
Key entities
- issuerGuardant Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderTariq Musa
Director who sold 116 shares in an open-market transaction under a pre-arranged 10b5-1 plan.
